Tomas-Sanchez C, Blanco-Alvarez V, Martinez-Fong D, Gonzalez-Barrios J, Gonzalez-Vazquez A, Aguilar-Peralta A
Oxid Med Cell Longev. 2018; 2018:9416432.
PMID: 30258527
PMC: 6146673.
DOI: 10.1155/2018/9416432.
Markus T, Ley D, Hansson S, Wieloch T, Ruscher K
BMC Neurosci. 2018; 19(1):9.
PMID: 29523072
PMC: 5845293.
DOI: 10.1186/s12868-018-0415-2.
Davis S, Pennypacker K
Neurochem Int. 2017; 107:23-32.
PMID: 28043837
PMC: 5461189.
DOI: 10.1016/j.neuint.2016.12.007.
Davis S, Collier L, Leonardo C, Seifert H, Ajmo Jr C, Pennypacker K
Mol Neurobiol. 2016; 54(1):608-622.
PMID: 26746670
PMC: 5026633.
DOI: 10.1007/s12035-015-9587-2.
Lei X, Zhu J, Cheng W, Bao Y, Ho Y, Reddi A
Physiol Rev. 2015; 96(1):307-64.
PMID: 26681794
PMC: 4839492.
DOI: 10.1152/physrev.00010.2014.
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Mohammedi K, Bellili-Munoz N, Marklund S, Driss F, Le Nagard H, Patente T
Cardiovasc Diabetol. 2015; 14:845.
PMID: 25855220
PMC: 4324771.
DOI: 10.1186/s12933-014-0163-2.
Overexpression of extracellular superoxide dismutase protects against brain injury induced by chronic hypoxia.
Zaghloul N, Patel H, Codipilly C, Marambaud P, Dewey S, Frattini S
PLoS One. 2014; 9(9):e108168.
PMID: 25268361
PMC: 4182464.
DOI: 10.1371/journal.pone.0108168.
NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.
McCann S, Roulston C
Brain Sci. 2014; 3(2):561-98.
PMID: 24961415
PMC: 4061864.
DOI: 10.3390/brainsci3020561.
Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts.
Pan Q, Qin X, Ma S, Wang H, Cheng K, Song X
Theranostics. 2014; 4(5):475-86.
PMID: 24669277
PMC: 3964442.
DOI: 10.7150/thno.7729.
The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.
Dani C, Poggi C
Antioxid Redox Signal. 2014; 21(13):1863-80.
PMID: 24382101
PMC: 4203110.
DOI: 10.1089/ars.2013.5811.
Extracellular superoxide dismutase induced by dopamine in cultured astrocytes.
Takano K, Tanaka N, Kawabe K, Moriyama M, Nakamura Y
Neurochem Res. 2012; 38(1):32-41.
PMID: 22983620
DOI: 10.1007/s11064-012-0882-2.
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia.
Armogida M, Nistico R, Mercuri N
Br J Pharmacol. 2012; 166(4):1211-24.
PMID: 22352897
PMC: 3417441.
DOI: 10.1111/j.1476-5381.2012.01912.x.
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?.
Dawson J, Walters M
Br J Clin Pharmacol. 2011; 62(6):633-44.
PMID: 21894646
PMC: 1885190.
DOI: 10.1111/j.1365-2125.2006.02785.x.
Irradiation enhances hippocampus-dependent cognition in mice deficient in extracellular superoxide dismutase.
Raber J, Villasana L, Rosenberg J, Zou Y, Huang T, Fike J
Hippocampus. 2009; 21(1):72-80.
PMID: 20020436
PMC: 2891276.
DOI: 10.1002/hipo.20724.
Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.
Niizuma K, Yoshioka H, Chen H, Kim G, Jung J, Katsu M
Biochim Biophys Acta. 2009; 1802(1):92-9.
PMID: 19751828
PMC: 2790539.
DOI: 10.1016/j.bbadis.2009.09.002.
Protective effect of extracellular superoxide dismutase on endothelial function during aging.
Lund D, Chu Y, Miller J, Heistad D
Am J Physiol Heart Circ Physiol. 2009; 296(6):H1920-5.
PMID: 19376805
PMC: 2716111.
DOI: 10.1152/ajpheart.01342.2008.
Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa.
Usui S, Komeima K, Lee S, Jo Y, Ueno S, Rogers B
Mol Ther. 2009; 17(5):778-86.
PMID: 19293779
PMC: 2803613.
DOI: 10.1038/mt.2009.47.
Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector.
Peluffo H, Acarin L, Aris A, Gonzalez P, Villaverde A, Castellano B
BMC Neurosci. 2006; 7:35.
PMID: 16638118
PMC: 1462999.
DOI: 10.1186/1471-2202-7-35.
Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.
Potts M, Koh S, Whetstone W, Walker B, Yoneyama T, Claus C
NeuroRx. 2006; 3(2):143-53.
PMID: 16554253
PMC: 3593438.
DOI: 10.1016/j.nurx.2006.01.006.
Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis.
Fujimura M, Tominaga T, Chan P
Neurocrit Care. 2005; 2(1):59-66.
PMID: 16174972
DOI: 10.1385/NCC:2:1:059.